 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.6 |
-1.64 % |
$ 8.66 B |
Australia |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
16.8 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
2.47 |
- |
- |
$ 546 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 21.54 |
0.84 % |
$ 1.01 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Clearside Biomedical
CLSD
|
61.7 |
- |
- |
$ 25.3 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
62.9 |
$ 1.53 |
3.74 % |
$ 393 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 3.03 |
3.77 % |
$ 4.99 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
103 |
$ 4.21 |
0.48 % |
$ 450 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 25.19 |
4.42 % |
$ 3.21 B |
USA |
 |
Chimerix
CMRX
|
588 |
- |
- |
$ 756 M |
USA |
 |
Concert Pharmaceuticals
CNCE
|
147 |
- |
- |
$ 401 M |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
321 |
$ 33.26 |
2.04 % |
$ 2.21 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.51 |
2.38 % |
$ 402 M |
Britain |
 |
Cidara Therapeutics
CDTX
|
2.26 K |
- |
- |
$ 1.41 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
CTI BioPharma Corp.
CTIC
|
52.1 |
- |
- |
$ 1.2 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |